Anticipating Obstacles to Approval Before Your Early Phase Oncology Study: Four Critical Areas to Consider
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have rigorous processes for reviewing applications for new drugs for marketing. By working with an experienced partner who can focus on the approval process from preclinical studies up to pivotal clinical investigations for you, the development is more likely to proceed along […]
How Feasible is Feasibility in Clinical Trials?
Original Air Date: Wednesday, January 29th 2020 Time: 10 am (EST) | 7 am (PST) | 3 pm (CET) Feasibility is often considered the process to determine if a clinical site and investigator are a good fit for a clinical trial when in fact, feasibility assessments begin long before site evaluations. With trials becoming more […]